Generic Name and Formulations:
Granisetron (as HCl) 1mg/5mL; soln; orange-flavor.
Indications for GRANISOL:
Prevention of nausea and vomiting associated with chemotherapy (including high-dose cisplatin) or with radiation (including total body irradiation and fractionated abdominal radiation).
Chemotherapy: give only on the days chemo is given. 2mg once daily up to 1 hour before chemo; or, 1mg up to 1 hour before chemo, then 1mg 12 hours after 1st dose. Radiation: 2mg once daily within 1 hour of radiation.
Pre-existing arrhythmias or cardiac conduction disorders. Increased risk of QT prolongation: cardiac disease, on cardio-toxic chemotherapy, electrolyte abnormalities and/or concomitant drugs that prolong the QT interval. Abdominal surgery. May mask progressive ileus and/or gastric distention. Pregnancy (Cat.B). Nursing mothers.
Caution with drugs that affect CYP450 or drugs known to prolong the QT interval and/or are arrhythmogenic.
Selective 5-HT3 receptor antagonist.
Headache, asthenia, diarrhea, constipation, abdominal pain; QT prolongation.
- 30ml of 2mg/10ml bottle of oral solutions (Qty:1)
- appx. price $82.00
Sign Up for Free e-newsletters
- 2016 Recommended Immunization Schedule for Adults: What's Changed?
- 2016 Childhood and Adolescent Immunization Schedule Released
- First Sexually-Transmitted Zika Virus Case Confirmed in Texas
- Spiriva Respimat Gains Indication and New Dosage Strength
- To Rx or Not to Rx: Interventions to Improve Antibiotic Prescribing for Uncomplicated Acute RTI
- CDC Guidelines on Preventing Sexual Transmission of Zika Virus Issued
- CDC Updates Interim Zika Virus Guidelines for Pregnant Women and Women of Reproductive Age
- Daklinza Use Expanded to Cover Treatment in More HCV Patients
- Researchers Call for an Alternative Tdap Immunization Strategy for Adolescents
- FDA Announces Large Action Plan in Effort to Reverse the Opioid Epidemic